Treatment- Directly Observed Therapy (DOT)

This manual provides basic information on TB testing, and lists key points in evaluating, treating, and monitoring children and adolescents who have latent TB infection.

This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.

This manual describes the TB field investigation process including pre-investigation preparation, communication with individuals in the field, confidentiality, field safety, and working with community providers. A checklist to be used during field work is also included.

This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.

This guide provides the clinical and epidemiological aspects of tuberculosis in the context of the National Tuberculosis Programme (NTP) in 18 illustrated chapters. This guide is a comprehensive reference for anyone involved in the treatment, control, and prevention of tuberculosis and is especially geared to specialist physicians working in low-income countries.

This pamphlet discusses taking TB medicines, explains directly observed therapy, and the importance of taking all medications for the prescribed period of time.

This fact sheet explains the facts about DOT.

This manual presents guidelines for employers to implement TB control activities in the workplace.

This report presents a tools package for public-private mix initiatives for DOTS implementation (PPM-DOTS) as a means of TB control. The purpose is to help national TB program (NTP) managers begin involving private providers (PPs) in DOTS implementation and to sustain collaboration.

This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.